GLITARIS 30

Glitaris 30 Tablet is indicated for the management of type 2 diabetes mellitus in adult patients. This medication assists in regulating blood glucose levels, thereby minimizing the risk of severe complications associated with diabetes, such as renal impairment and vision loss. Glitaris 30 can be administered alone or in combination with other antidiabetic agents. It can be taken with or without meals, but to achieve optimal results, it is advised to take it consistently at the same time each day. The prescribing physician will determine the appropriate dosage, which may be adjusted periodically based on the patient’s response to treatment. It is important to continue taking this medication even if you achieve a sense of well-being or observe stable blood sugar levels; abrupt discontinuation without medical advice may result in elevated blood sugar levels, increasing the likelihood of serious complications including kidney damage, blindness, neuropathy, and potential limb loss. This medication should be considered as part of a comprehensive treatment approach that includes adhering to a nutritious diet, engaging in regular physical activity, and achieving weight management as directed by your healthcare provider. Lifestyle choices play a crucial role in the effective management of diabetes. Individuals must be cautious about taking Glitaris 30 if they have type 1 diabetes, diabetic ketoacidosis, or significant renal or hepatic conditions. Prior to starting this medication, it is essential to inform your healthcare professional of any previous cardiovascular issues, thyroid disorders, or hormonal imbalances, as these may impact suitability. Regular monitoring of blood glucose levels is essential, and additional blood tests may be required to assess blood cell counts and liver function.